Efficacy and Safety of Alirocumab in High-Risk Patients with Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (From 5 Placebo-Controlled ODYSSEY Trials)
McCullough, Peter A., Ballantyne, Christie M., Sanganalmath, Santosh K., Langslet, Gisle, Baum, Seth J., Shah, Prediman K., Koren, Andrew, Mandel, Jonas, Davidson, Michael H.Language:
english
Journal:
The American Journal of Cardiology
DOI:
10.1016/j.amjcard.2017.12.040
Date:
February, 2018
File:
PDF, 1.40 MB
english, 2018